Bladder cancer is one of the most incident neoplasms worldwide, and its treatment remains a significant challenge, since the mechanisms underlying disease progression are still poorly understood. The epithelial to mesenchymal transition (EMT) has been proven to play an important role in the tumorigenic process, particularly in cancer cell invasiveness and metastatic potential. Several studies have reported the importance of epigenetic mechanisms and enzymes, which orchestrate them in several features of cancer cells and, specifically, in EMT. In this paper, we discuss the epigenetic enzymes, protein-coding and non-coding genes, and mechanisms altered in the EMT process occurring in bladder cancer cells, as well as its implications, which al...
The development and progression of high-grade non-muscle invasive bladder cancer (NMIBC) results fro...
Bladder cancer (BC) is the 10th most frequent type of cancer worldwide, with around 549.000 new case...
Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnos...
Bladder cancer is one of the most common cancers of urinary system and approximately 70% of the case...
Urothelial carcinoma (UC), the most common type of bladder cancer, is one of the most expensive mali...
Bladder cancer is one of the most common cancers worldwide, with a high rate of recurrence and poor ...
The epithelial-mesenchymal transition (EMT) is a morphogenetic process that results in a loss of epi...
Tumor metastasis is the major cause of mortality and morbidity in most solid cancers. A growing body...
Background:Elucidation of epigenetic alterations in bladder cancer will lead to further understandin...
Context: Epithelial to mesenchymal transition (EMT) is a process involving conversion of cells from ...
Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease that often recurs despite aggressiv...
Epithelial-to-mesenchymal transition (EMT) is an essential biological process involved in embryonic ...
The escalating prevalence of bladder cancer, particularly urothelial carcinoma, necessitates innovat...
Epigenetic regulation of gene expression IS commonly altered in human cancer. Numerous alterations o...
BACKGROUND: Despite adequate treatment and follow-up, around one fifth of patients with localized bl...
The development and progression of high-grade non-muscle invasive bladder cancer (NMIBC) results fro...
Bladder cancer (BC) is the 10th most frequent type of cancer worldwide, with around 549.000 new case...
Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnos...
Bladder cancer is one of the most common cancers of urinary system and approximately 70% of the case...
Urothelial carcinoma (UC), the most common type of bladder cancer, is one of the most expensive mali...
Bladder cancer is one of the most common cancers worldwide, with a high rate of recurrence and poor ...
The epithelial-mesenchymal transition (EMT) is a morphogenetic process that results in a loss of epi...
Tumor metastasis is the major cause of mortality and morbidity in most solid cancers. A growing body...
Background:Elucidation of epigenetic alterations in bladder cancer will lead to further understandin...
Context: Epithelial to mesenchymal transition (EMT) is a process involving conversion of cells from ...
Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease that often recurs despite aggressiv...
Epithelial-to-mesenchymal transition (EMT) is an essential biological process involved in embryonic ...
The escalating prevalence of bladder cancer, particularly urothelial carcinoma, necessitates innovat...
Epigenetic regulation of gene expression IS commonly altered in human cancer. Numerous alterations o...
BACKGROUND: Despite adequate treatment and follow-up, around one fifth of patients with localized bl...
The development and progression of high-grade non-muscle invasive bladder cancer (NMIBC) results fro...
Bladder cancer (BC) is the 10th most frequent type of cancer worldwide, with around 549.000 new case...
Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnos...